Drugs / [18F]FPyQCP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07432633 | Feb 2026 → Jan 2028 expected | colorectal cancer, gastric cancer, invasive lobular breast carcinoma, malignant epithelial tumor of ovary +1 | Blue Earth Diagnostics | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]FPyQCP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07432633 ↗ |
| Modality | Diagnostic / imaging agent | “positron emission tomography (PET)/computed tomography (CT) imaging” NCT07432633 ↗ |